Universe Pharmaceuticals INC (UPC)

Market Cap	3.33M
Revenue (ttm)	26.73M
Net Income (ttm)	-18.55M
Shares Out	23.65M
EPS (ttm)	-5.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,118,232
Open	0.163
Previous Close	0.162
Day's Range	0.120 - 0.165
52-Week Range	0.120 - 4.320
Beta	1.54
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About UPC

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceut...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Mar 23, 2021
• Employees: 225
• Stock Exchange: NASDAQ
• Ticker Symbol: UPC
• Website: https://www.universe-pharmacy.com

Financial Performance

In 2023, UPC's revenue was $32.31 million, a decrease of -19.52% compared to the previous year's $40.14 million. Losses were -$6.16 million, -29.46% less than in 2022.